← Scoopfeeds — Intelligent news, curated.
Palisade Bio (PALI) Reports Q1 2026 Results as R&D Expenses Rise to $6.4M
business

Palisade Bio (PALI) Reports Q1 2026 Results as R&D Expenses Rise to $6.4M

Yahoo Finance · May 18, 2026, 4:49 AM · Also reported by 3 other sources

Palisade Bio (PALI) Reports Q1 2026 Results as R&D Expenses Rise to $6.4M

Read full story on Yahoo Finance → More top stories

Also covered by

Investing.com Earnings call transcript: iHeartMedia Q1 2026 reveals mixed results with EPS miss Investing.com Earnings call transcript: BuzzFeed Q1 2026 results show revenue decline Investing.com Earnings call transcript: Harrow Health Q1 2026 results miss expectations

More in business

Investing.com
U.S. drill bit makers ramp up shift to steel as tungsten prices surge
Investing.com
Judge blocks Kansas ban on gender-transition treatment for minors
Investing.com
Starz Entertainment shareholders approve board nominees and annual say-on-pay vote
Investing.com
Ford to build Bronco SUV in Spain as part of European revival plan
Investing.com
Luigi Mangione due in court for ruling on backpack evidence in CEO killing case
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop